The prognostic value of the pan-immune-inflammation value in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Objective Immune checkpoint inhibitors (ICIs) show substantial therapeutic potential in advanced or metastatic solid malignancies, yet optimization of clinical benefit remains an unmet need. This systematic review and meta-analysis evaluates the pretreatment pan-immune-inflammation value (PIV) as a prognostic biomarker...